{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:11:30Z","timestamp":1788865890527,"version":"build-2803163510"},"reference-count":52,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Our study aimed to assess the relationship between serum adipokines and insulin resistance (IR) in women with polycystic ovary syndrome (PCOS) and explore the predictive value of adipokines on IR in PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective cross-sectional study. 154 women with PCOS were included from July 2021 to September 2022 who underwent gonadal steroid hormone measurement, lipid profile, oral glucose tolerance test and homoeostasis model assessment (HOMA)-IR. Adiponectin (APN), leptin and secreted frizzled-related protein (Sfrp5) were measured by immunoturbidimetry and enzyme-linked immunosorbent assay. Women with PCOS were categorised based on the presence of IR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Women with PCOS with IR (\n                      <jats:italic>n<\/jats:italic>\n                      = 99) had significantly lower APN level and APN-to-leptin ratio (A\/L ratio) than those without IR (\n                      <jats:italic>n<\/jats:italic>\n                      = 55), whereas serum levels of leptin and Sfrp5 were similar between the two groups. In multivariable linear regression analysis, serum log (APN) and log (A\/L ratio) were associated with log (HOMA-IR), and the association was statistically significant after adjusting for body mass index and free androgen index. The area under the receiver operating characteristic curve (95% CI) for APN and A\/L ratio was 0.726 (0.644\u20130.807;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001) and 0.660 (0.569\u20130.751;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.01), respectively, with cutoff values of 5.225 mg\/L (Youden index \u00bc 0.364) and 1.438 mg\/L (Youden index \u00bc 0.265).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study demonstrated that serum APN was negatively related to IR. Serum APN may be useful as a clinical marker for IR in women with PCOS. Our findings warrant further investigations into the function of APN in the pathogenesis of IR in women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0401","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:22:32Z","timestamp":1730298152000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":4,"title":["Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1912-6138","authenticated-orcid":true,"given":"Jie","family":"Yang","sequence":"first","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lin","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, The First People\u2019s Hospital of Yulin, Yulin, Guangxi Zhuang Autonomous Region, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Tian","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujun","family":"Li","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Deng","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1018-9922","authenticated-orcid":true,"given":"Xuelan","family":"Li","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0561-0635","authenticated-orcid":true,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[{"name":"Reproductive Medicine Center, Shunde Hospital of Southern Medical University (The First People's Hospital of Shunde), Foshan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib2","series-title":"J Stomatol Oral Maxillofac Surg","first-page":"544","article-title":"The novel relationship between polycystic ovary syndrome and temporomandibular joint disorders","volume":"122","author":"Yazici H","year":"2021","unstructured":"Yazici H, Taskin MI, Guney G, et al. The novel relationship between polycystic ovary syndrome and temporomandibular joint disorders. J Stomatol Oral Maxillofac Surg 2021 122 544\u2013548. (https:\/\/doi.org\/10.1016\/j.jormas.2020.10.008)"},{"key":"bib3","series-title":"J Clin Endocrinol Metab","first-page":"2447","article-title":"Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of polycystic ovary syndrome","volume":"108","author":"Teede HJ","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of polycystic ovary syndrome. J Clin Endocrinol Metab 2023 108 2447\u20132469. (https:\/\/doi.org\/10.1210\/clinem\/dgad463)"},{"key":"bib4","series-title":"J Clin Endocrinol Metab","first-page":"4325","article-title":"Renaming PCOS\u2014a two-state solution","volume":"98","author":"Dunaif A","year":"2013","unstructured":"Dunaif A & Fauser BC. Renaming PCOS\u2014a two-state solution. J Clin Endocrinol Metab 2013 98 4325\u20134328. (https:\/\/doi.org\/10.1210\/jc.2013-2040)"},{"key":"bib5","series-title":"Nat Rev Endocrinol","first-page":"130","article-title":"Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS","volume":"10","author":"Orio F","year":"2014","unstructured":"Orio F & Palomba S. Reproductive endocrinology: new guidelines for the diagnosis and treatment of PCOS. Nat Rev Endocrinol 2014 10 130\u2013132. (https:\/\/doi.org\/10.1038\/nrendo.2013.248)"},{"key":"bib6","series-title":"Ther Adv Endocrinol Metab","article-title":"Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study","volume":"12","author":"Guney G","year":"2021","unstructured":"Guney G, Taskin MI, Baykan O, et al. Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study. Ther Adv Endocrinol Metab 2021 12 20420188211049607. (https:\/\/doi.org\/10.1177\/20420188211049607)"},{"key":"bib7","series-title":"Biomedicines","first-page":"355","article-title":"Oncostatin M is related to polycystic ovary syndrome-case control study","volume":"12","author":"Camili FE","year":"2024","unstructured":"Camili FE, Akis M, Adali E, et al. Oncostatin M is related to polycystic ovary syndrome-case control study. Biomedicines 2024 12 355. (https:\/\/doi.org\/10.3390\/biomedicines12020355)"},{"key":"bib8","series-title":"Nutrients","first-page":"1387","article-title":"A comparison of a pulse-based diet and the therapeutic lifestyle changes diet in combination with exercise and health counselling on the cardio-metabolic risk profile in women with polycystic ovary syndrome: a randomized controlled trial","volume":"10","author":"Kazemi M","year":"2018","unstructured":"Kazemi M, McBreairty LE, Chizen DR, et al. A comparison of a pulse-based diet and the therapeutic lifestyle changes diet in combination with exercise and health counselling on the cardio-metabolic risk profile in women with polycystic ovary syndrome: a randomized controlled trial. Nutrients 2018 10 1387. (https:\/\/doi.org\/10.3390\/nu10101387)"},{"key":"bib9","series-title":"J Hum Reprod Sci","first-page":"194","article-title":"Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: a prospective study of PCOS women","volume":"6","author":"Kar S","year":"2013","unstructured":"Kar S. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: a prospective study of PCOS women. J Hum Reprod Sci 2013 6 194\u2013200. (https:\/\/doi.org\/10.4103\/0974-1208.121422)"},{"key":"bib10","series-title":"Fertil Steril","first-page":"827","article-title":"Insulin resistance in polycystic ovary syndrome: concept versus cutoff","volume":"112","author":"Greenwood EA","year":"2019","unstructured":"Greenwood EA & Huddleston HG. Insulin resistance in polycystic ovary syndrome: concept versus cutoff. Fertil Steril 2019 112 827\u2013828. (https:\/\/doi.org\/10.1016\/j.fertnstert.2019.08.100)"},{"key":"bib11","series-title":"Int J Endocrinol Metab","first-page":"e12353","article-title":"Optimal cutoff points for anthropometric variables to predict insulin resistance in polycystic ovary syndrome","volume":"15","author":"Hatami H","year":"2017","unstructured":"Hatami H, Montazeri SA, Hashemi N, et al. Optimal cutoff points for anthropometric variables to predict insulin resistance in polycystic ovary syndrome. Int J Endocrinol Metab 2017 15 e12353. (https:\/\/doi.org\/10.5812\/ijem.12353)"},{"key":"bib12","series-title":"Fertil Steril","first-page":"753","article-title":"Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome","volume":"115","author":"Chen Y","year":"2021","unstructured":"Chen Y, Zheng X, Ma D, et al. Neck circumference is a good predictor for insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2021 115 753\u2013760. (https:\/\/doi.org\/10.1016\/j.fertnstert.2020.07.027)"},{"key":"bib13","series-title":"Endocr Rev","first-page":"467","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield RL","year":"2016","unstructured":"Rosenfield RL & Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 2016 37 467\u2013520. (https:\/\/doi.org\/10.1210\/er.2015-1104)"},{"key":"bib14","series-title":"Clin Endocrinol","first-page":"138","article-title":"Prevalence and degree of insulin resistance in Chinese Han women with PCOS: results from euglycemic-hyperinsulinemic clamps","volume":"90","author":"Li W","year":"2019","unstructured":"Li W, Chen Q, Xie Y, et al. Prevalence and degree of insulin resistance in Chinese Han women with PCOS: results from euglycemic-hyperinsulinemic clamps. Clin Endocrinol 2019 90 138\u2013144. (https:\/\/doi.org\/10.1111\/cen.13860)"},{"key":"bib15","series-title":"J Endocrinol Invest","first-page":"1","article-title":"New markers of insulin resistance in polycystic ovary syndrome","volume":"40","author":"Polak K","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest 2017 40 1\u20138. (https:\/\/doi.org\/10.1007\/s40618-016-0523-8)"},{"key":"bib16","series-title":"J Clin Hypertens","first-page":"529","article-title":"Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension","volume":"23","author":"Minh HV","year":"2021","unstructured":"Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens 2021 23 529\u2013537. (https:\/\/doi.org\/10.1111\/jch.14155)"},{"key":"bib17","series-title":"Fertil Steril","first-page":"887","article-title":"Cardiometabolic biomarkers in women with polycystic ovary syndrome","volume":"117","author":"van der Ham K","year":"2022","unstructured":"van der Ham K, Louwers YV & Laven JSE. Cardiometabolic biomarkers in women with polycystic ovary syndrome. Fertil Steril 2022 117 887\u2013896. (https:\/\/doi.org\/10.1016\/j.fertnstert.2022.03.008)"},{"key":"bib18","series-title":"Front Endocrinol","first-page":"537809","article-title":"Circulating adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis","volume":"11","author":"Lin K","year":"2021","unstructured":"Lin K, Sun X, Wang X, et al. Circulating adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis. Front Endocrinol 2021 11 537809. (https:\/\/doi.org\/10.3389\/fendo.2020.537809)"},{"key":"bib19","series-title":"Front Endocrinol","first-page":"881684","article-title":"Progress of adipokines in the female reproductive system: a focus on polycystic ovary syndrome","volume":"13","author":"Chen P","year":"2022","unstructured":"Chen P, Jia R, Liu Y, et al. Progress of adipokines in the female reproductive system: a focus on polycystic ovary syndrome. Front Endocrinol 2022 13 881684. (https:\/\/doi.org\/10.3389\/fendo.2022.881684)"},{"key":"bib20","series-title":"Endocr Rev","first-page":"812","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva HS","year":"2012","unstructured":"Randeva HS, Tan BK, Weickert MO, et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 2012 33 812\u2013841. (https:\/\/doi.org\/10.1210\/er.2012-1003)"},{"key":"bib21","series-title":"J Ovarian Res","first-page":"97","article-title":"Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism","volume":"14","author":"Zhang Y","year":"2021","unstructured":"Zhang Y, Ran Y, Kong L, et al. Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism. J Ovarian Res 2021 14 97. (https:\/\/doi.org\/10.1186\/s13048-021-00847-4)"},{"key":"bib22","series-title":"Front Endocrinol","first-page":"845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng Y","year":"2022","unstructured":"Peng Y, Yang H, Song J, et al. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol 2022 13 845165. (https:\/\/doi.org\/10.3389\/fendo.2022.845165)"},{"key":"bib23","series-title":"Fertil Steril","first-page":"460","article-title":"Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome","volume":"104","author":"Sarray S","year":"2015","unstructured":"Sarray S, Madan S, Saleh LR, et al. Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. Fertil Steril 2015 104 460\u2013466. (https:\/\/doi.org\/10.1016\/j.fertnstert.2015.05.007)"},{"issue":"Supplement 2","key":"bib24","series-title":"Diabetes Metab Syndr","first-page":"S697","article-title":"L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome","volume":"11","author":"Gupta V","year":"2017","unstructured":"Gupta V, Mishra S, Mishra S, et al. L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome. Diabetes Metab Syndr 2017 11 (Supplement 2) S697\u2013s701. (https:\/\/doi.org\/10.1016\/j.dsx.2017.05.001)"},{"key":"bib25","series-title":"Fertil Steril","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"EA-SPCWG Rotterdam","year":"2004","unstructured":"EA-SPCWG Rotterdam. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004 81 19\u201325. (https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004)"},{"key":"bib26","series-title":"Endokrynol Pol","first-page":"181","article-title":"The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome","volume":"65","author":"Lenarcik-Kabza A","year":"2014","unstructured":"Lenarcik-Kabza A, Laczmanski L, Milewicz A, et al. The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome. Endokrynol Pol 2014 65 181\u2013188. (https:\/\/doi.org\/10.5603\/EP.2014.0025)"},{"key":"bib27","series-title":"Health Promot Perspect","first-page":"206","article-title":"Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome","volume":"3","author":"Saghafi-Asl M","year":"2013","unstructured":"Saghafi-Asl M, Pirouzpanah S, Ebrahimi-Mameghani M, et al. Lipid profile in relation to anthropometric indices and insulin resistance in overweight women with polycystic ovary syndrome. Health Promot Perspect 2013 3 206\u2013216. (https:\/\/doi.org\/10.5681\/hpp.2013.024)"},{"key":"bib28","series-title":"J Clin Endocrinol Metab","first-page":"3666","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen A","year":"1999","unstructured":"Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999 84 3666\u20133672. (https:\/\/doi.org\/10.1210\/jcem.84.10.6079)"},{"key":"bib29","series-title":"Diabetes Care","first-page":"3320","article-title":"Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism","volume":"26","author":"Ascaso JF","year":"2003","unstructured":"Ascaso JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003 26 3320\u20133325. (https:\/\/doi.org\/10.2337\/diacare.26.12.3320)"},{"key":"bib30","series-title":"Am J Physiol Endocrinol Metab","first-page":"E115","article-title":"Decreased adiponectin\/leptin ratio relates to insulin resistance in adults with obesity","volume":"324","author":"Castela I","year":"2023","unstructured":"Castela I, Morais J, Barreiros-Mota I, et al. Decreased adiponectin\/leptin ratio relates to insulin resistance in adults with obesity. Am J Physiol Endocrinol Metab 2023 324 E115\u2013e119. (https:\/\/doi.org\/10.1152\/ajpendo.00273.2022)"},{"key":"bib31","series-title":"Arterioscler Thromb Vasc Biol","first-page":"e19","article-title":"Adiponectin and long-term mortality in coronary artery disease participants and controls","volume":"33","author":"Hascoet S","year":"2013","unstructured":"Hascoet S, Elbaz M, Bongard V, et al. Adiponectin and long-term mortality in coronary artery disease participants and controls. Arterioscler Thromb Vasc Biol 2013 33 e19\u2013e29. (https:\/\/doi.org\/10.1161\/atvbaha.112.300079)"},{"key":"bib32","series-title":"Front Endocrinol","first-page":"774272","article-title":"The variation and correlation of serum adiponectin, nesfatin-1, IL-6, and TNF-\u03b1 levels in prediabetes","volume":"13","author":"Huang K","year":"2022","unstructured":"Huang K, Liang Y, Ma Y, et al. The variation and correlation of serum adiponectin, nesfatin-1, IL-6, and TNF-\u03b1 levels in prediabetes. Front Endocrinol 2022 13 774272. (https:\/\/doi.org\/10.3389\/fendo.2022.774272)"},{"key":"bib33","series-title":"J Clin Endocrinol Metab","first-page":"1930","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer C","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001 86 1930\u20131935. (https:\/\/doi.org\/10.1210\/jcem.86.5.7463)"},{"key":"bib34","series-title":"J Clin Endocrinol Metab","first-page":"e1897","article-title":"Insulin resistance and hyperinsulinemia: the egg and the chicken","volume":"106","author":"Abdul-Ghani M","year":"2021","unstructured":"Abdul-Ghani M & DeFronzo RA. Insulin resistance and hyperinsulinemia: the egg and the chicken. J Clin Endocrinol Metab 2021 106 e1897\u2013e1899. (https:\/\/doi.org\/10.1210\/clinem\/dgaa364)"},{"key":"bib35","series-title":"Fertil Steril","first-page":"1708","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi MS","year":"2005","unstructured":"Ardawi MS & Rouzi AA. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2005 83 1708\u20131716. (https:\/\/doi.org\/10.1016\/j.fertnstert.2004.11.077)"},{"key":"bib36","series-title":"Fertil Steril","first-page":"1200","article-title":"Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action","volume":"89","author":"Aroda V","year":"2008","unstructured":"Aroda V, Ciaraldi TP, Chang SA, et al. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin action. Fertil Steril 2008 89 1200\u20131208. (https:\/\/doi.org\/10.1016\/j.fertnstert.2007.04.046)"},{"key":"bib37","series-title":"Tumour Biol","first-page":"3961","article-title":"Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis","volume":"35","author":"Li S","year":"2014","unstructured":"Li S, Huang X, Zhong H, et al. Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis. Tumour Biol 2014 35 3961\u20133973. (https:\/\/doi.org\/10.1007\/s13277-013-1595-0)"},{"key":"bib38","series-title":"Gynecol Obstet Invest","first-page":"155","article-title":"Determinants of circulating adiponectin in women with polycystic ovary syndrome","volume":"60","author":"Vrb\u00edkov\u00e1 J","year":"2005","unstructured":"Vrb\u00edkov\u00e1 J, Dvor\u00e1kov\u00e1 K, Hill M, et al. Determinants of circulating adiponectin in women with polycystic ovary syndrome. Gynecol Obstet Invest 2005 60 155\u2013161. (https:\/\/doi.org\/10.1159\/000086273)"},{"key":"bib39","series-title":"Fertil Steril","first-page":"642","article-title":"Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome","volume":"89","author":"Carmina E","year":"2008","unstructured":"Carmina E, Chu MC, Moran C, et al. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 2008 89 642\u2013648. (https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.085)"},{"key":"bib40","series-title":"J Clin Endocrinol Metab","first-page":"E304","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manner\u00e5s-Holm L","year":"2011","unstructured":"Manner\u00e5s-Holm L, Leonhardt H, Kullberg J, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011 96 E304\u2013E311. (https:\/\/doi.org\/10.1210\/jc.2010-1290)"},{"key":"bib41","series-title":"J Soc Gynecol Investig","first-page":"129","article-title":"Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance","volume":"12","author":"Sepilian V","year":"2005","unstructured":"Sepilian V & Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 2005 12 129\u2013134. (https:\/\/doi.org\/10.1016\/j.jsgi.2004.09.003)"},{"key":"bib42","series-title":"Int J Fertil Steril","first-page":"331","article-title":"Serum adiponectin level and clinical, metabolic, and hormonal markers in patients with polycystic ovary syndrome","volume":"7","author":"Yildiz Y","year":"2014","unstructured":"Yildiz Y, Ozaksit G, Serdar Unlu B, et al. Serum adiponectin level and clinical, metabolic, and hormonal markers in patients with polycystic ovary syndrome. Int J Fertil Steril 2014 7 331\u2013336"},{"key":"bib43","series-title":"J Clin Invest","first-page":"1875","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30","volume":"108","author":"Combs TP","year":"2001","unstructured":"Combs TP, Berg AH, Obici S, et al. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001 108 1875\u20131881. (https:\/\/doi.org\/10.1172\/jci14120)"},{"key":"bib44","series-title":"Nature","first-page":"1313","article-title":"Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK\/SIRT1","volume":"464","author":"Iwabu M","year":"2010","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK\/SIRT1. Nature 2010 464 1313\u20131319. (https:\/\/doi.org\/10.1038\/nature08991)"},{"key":"bib45","series-title":"Nat Med","first-page":"731","article-title":"Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30","volume":"8","author":"Maeda N","year":"2002","unstructured":"Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med 2002 8 731\u2013737. (https:\/\/doi.org\/10.1038\/nm724)"},{"key":"bib46","series-title":"J Biol Chem","first-page":"25863","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota N","year":"19 2002","unstructured":"Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 19 2002 277 25863\u201325866. (https:\/\/doi.org\/10.1074\/jbc.C200251200)"},{"key":"bib47","series-title":"Diabetologia","first-page":"932","article-title":"Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice","volume":"61","author":"Xia JY","year":"2018","unstructured":"Xia JY, Sun K, Hepler C, et al. Acute loss of adipose tissue-derived adiponectin triggers immediate metabolic deterioration in mice. Diabetologia 2018 61 932\u2013941. (https:\/\/doi.org\/10.1007\/s00125-017-4516-8)"},{"key":"bib48","series-title":"J Clin Invest","first-page":"4041","article-title":"Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome","volume":"129","author":"Kita S","year":"2019","unstructured":"Kita S, Maeda N & Shimomura I. Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome. J Clin Invest 2019 129 4041\u20134049. (https:\/\/doi.org\/10.1172\/jci129193)"},{"key":"bib49","series-title":"Proc Natl Acad Sci USA","first-page":"32584","article-title":"Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice","volume":"117","author":"Li X","year":"2020","unstructured":"Li X, Zhang D, Vatner DF, et al. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proc Natl Acad Sci USA 2020 117 32584\u201332593. (https:\/\/doi.org\/10.1073\/pnas.1922169117)"},{"key":"bib50","series-title":"J Ovarian Res","first-page":"15","article-title":"Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring","volume":"14","author":"Zuo M","year":"2021","unstructured":"Zuo M, Liao G, Zhang W, et al. Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring. J Ovarian Res 2021 14 15. (https:\/\/doi.org\/10.1186\/s13048-020-00755-z)"},{"key":"bib51","series-title":"Proc Natl Acad Sci USA","first-page":"E7187","article-title":"Adiponectin protects against development of metabolic disturbances in a PCOS mouse model","volume":"114","author":"Benrick A","year":"2017","unstructured":"Benrick A, Chancl\u00f3n B, Micallef P, et al. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proc Natl Acad Sci USA 2017 114 E7187\u2013e7196. (https:\/\/doi.org\/10.1073\/pnas.1708854114)"},{"key":"bib52","series-title":"Crit Rev Clin Lab Sci","first-page":"180","article-title":"Biomarkers of insulin sensitivity and insulin resistance: past, present and future","volume":"52","author":"Park SE","year":"2015","unstructured":"Park SE, Park CY & Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: past, present and future. Crit Rev Clin Lab Sci 2015 52 180\u2013190. (https:\/\/doi.org\/10.3109\/10408363.2015.1023429)"},{"key":"bib53","series-title":"J Clin Endocrinol Metab","first-page":"4426","article-title":"Insulin sensitivity and its measurement: structural commonalities among the methods","volume":"85","author":"Radziuk J","year":"2000","unstructured":"Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000 85 4426\u20134433. (https:\/\/doi.org\/10.1210\/jcem.85.12.7025)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/1\/EC-24-0401.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/1\/EC-24-0401.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/1\/EC-24-0401.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:28Z","timestamp":1784555248000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":52,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0401","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}